ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 0555-0899-02
Published January 3, 2024 · Recall initiated: January 26, 2022
Summary
FDA records drug Class II recall D-0180-2024, published January 3, 2024 and initiated January 26, 2022. Recalling firm: CARDINAL HEALTHCARE; Status: Terminated; Reported quantity: 1 unit; Lot: Batch 100023687. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What to do
Voluntary: Firm initiated · Letter
Get an email if ESTRADIOL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ESTRADIOL
- Manufacturer
- CARDINAL HEALTHCARE
- Distributor
- Nationwide USA
- Lot
- Batch 100023687
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEstradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC,October 7, 2026
- FDAEstradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANIMay 27, 2026
- FDAEstradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila HealthcareJune 12, 2024
- FDAEstradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila HealthcareJune 12, 2024
- FDAEnoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For SubcutaneousJanuary 3, 2024
- FDAFIRST LANSOPRAZOLE PT 3MG/ML, 300ML, Rx Only, Distributed By: CutisPharma, Inc., Woburn, MA 01801. NDC:January 3, 2024
Questions about this recall
Was ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 0555-0899-02 recalled?
Yes. FDA published recall D-0180-2024 on January 3, 2024. Reported hazard: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ESTRADIOL.